Drug Approval | May 12, 2023
USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
Subscribe To Our Newsletter & Stay Updated
